genetic lesions driving pmbcl pathogenesis and outcomes
Published 2 years ago • 624 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
3:51
genetic mechanisms driving thrombocytopenia in mf patients
-
2:15
using gep to molecularly characterize & predict the outcomes of patients with pmbcl
-
1:32
genomic sequencing as a driver of advancements in pediatric hematology
-
15:11
genetic basis of immune evasion in lymphoid malignancies: more heterogenetity than we think?
-
2:06
identification of genetic markers associated with ibrutinib-related cardiovascular toxicity
-
5:15
impact of mmrd and eln genetic classification in outcomes for patients with aml underoging allohct
-
2:33
the effect of lymphodepleting agents on rate and severity of toxicities following car-t infusion
-
3:38
genetic ancestry: the implications for biology and prognosis of childhood all
-
1:03:27
lecture 13 - viral genetic systems
-
13:40
venetoclax for myeloma | therapies on the horizon #myeloma
-
22:42
genetic circuits
-
1:12
understanding genetic and non-genetic mechanisms involve in aml disease progression
-
3:31
global treatment patterns and outcomes among pts with chromosome translocation (11;14)-positive mm
-
2:12
the impact of genetic abnormalities on treatment decisions in cll
-
0:36
the use of ai for analyzing genetic and molecular data in cll
-
2:00
genetic mutations and inflammation: understanding the links and improving prognosis in mds
-
1:11
genetic dynamics and factors predictive of survival in relapsed aml
-
2:57
genetic biomarkers of response to venetoclax in aml
-
2:19
session highlights: autosct in t-cell lymphoma, classification updates and fertility preservation
-
2:51
genetic markers in patients with early-stage cll treated with ibrutinib: findings from cll12
-
13:20
a phase 3 study of biosimilar bi 695501 versus adalimumab in patients with crohn’s disease - vjbm
-
0:39
versiti diagnostic labs | hematology genetics